These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29961458)

  • 1. Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study.
    Mukhopadhyay S; Kumar M; Yusuf J; Gupta VK; Tyagi S
    Indian Heart J; 2018; 70(3):405-409. PubMed ID: 29961458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: A single centre experience.
    Sanghvi S; Mathur R; Baroopal A; Kumar A
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S290-S294. PubMed ID: 30595277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine.
    Mehta HH; Morris M; Fischman DL; Finley JJ; Ruggiero N; Walinsky P; McCarey M; Savage MP
    J Invasive Cardiol; 2019 Mar; 31(3):42-45. PubMed ID: 30555052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia.
    Yang Z; Yuan J; Cui J; Guan H; Qiao S
    BMC Cardiovasc Disord; 2021 Mar; 21(1):156. PubMed ID: 33781230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the relationship between a narrow fragmented QRS complex and coronary slow flow.
    Cakmak HA; Aslan S; Gul M; Kalkan AK; Ozturk D; Celik O; Tasbulak O; Satilmisoglu MH
    Cardiol J; 2015; 22(4):428-36. PubMed ID: 25588536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
    Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
    Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
    Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
    JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and coronary angiographic characteristics of patients with coronary slow flow.
    Yilmaz H; Demir I; Uyar Z
    Acta Cardiol; 2008 Oct; 63(5):579-84. PubMed ID: 19014000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary flow improvement following unsuccessful primary percutaneous coronary intervention in ST-elevation myocardial infarction with diffuse ectatic coronary artery.
    Fujii T; Sakai K; Kimura M; Nakano M; Ohno Y; Nakazawa G; Shinozaki N; Matsukage T; Yoshimachi F; Ikari Y
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):623-631. PubMed ID: 26880852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between coronary slow flow phenomenon and coronary calcium score.
    Oz O; Bayram NA; Durmaz T; Keles T; Akcay M; Bozkurt E
    Perfusion; 2010 Mar; 25(2):97-102. PubMed ID: 20427414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of no-reflow in culprit lesion versus culprit vessel PCI in acute STEMI.
    Arslan U; Yaman M; Kocaoğlu İ; Turan OE; Yücel H; Aksakal A; Günaydin İA; Hakan Ateş A
    Coron Artery Dis; 2015 Sep; 26(6):510-5. PubMed ID: 26086864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between coronary dominance and acute inferior myocardial infarction: a matched, case-control study.
    Wang L; Li J; Gao Y; Li R; Zhang J; Su D; Wang T; Yang G; Wang X
    BMC Cardiovasc Disord; 2019 Feb; 19(1):35. PubMed ID: 30717670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary slow flow--prevalence and clinical correlations.
    Hawkins BM; Stavrakis S; Rousan TA; Abu-Fadel M; Schechter E
    Circ J; 2012; 76(4):936-42. PubMed ID: 22293446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Magro M; Nauta ST; Simsek C; Boersma E; van der Heide E; Regar E; van Domburg RT; Zijlstra F; Serruys PW; van Geuns RJ
    Am J Cardiol; 2012 Mar; 109(5):601-6. PubMed ID: 22177003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-ST-elevation myocardial infarction with normal coronary arteries, clinical features and coronary artery flow].
    Carunchio A; Ricci R; Mazzarotto P; Danesi A; Caferri G; Ferraironi A; Faina E; Ceci V
    Ital Heart J Suppl; 2005 Apr; 6(4):205-13. PubMed ID: 15902943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.
    Celebi H; Catakoglu AB; Kurtoglu H; Sener M; Hanavdelogullari R; Demiroglu C; Aytekin V; Aytekin S
    Cardiovasc Revasc Med; 2008; 9(3):144-8. PubMed ID: 18606377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.